CompletedPhase 2NCT01560260
Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Studying Carney complex
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Margaret von MehrenSarcoma Alliance for Research through Collaboration
- Intervention
- Laboratory Biomarker Analysis(other)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2015
Study locations (8)
- Stanford Cancer Institute, Palo Alto, California, United States
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, United States
- Sarcoma Alliance for Research Through Collaboration, Ann Arbor, Michigan, United States
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- Oregon Health and Science University, Portland, Oregon, United States
- Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01560260 on ClinicalTrials.gov